Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Miquel Navasa

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Liver Transplantation

Physiology

Anatomy

Liver

Concepts & Ideas

Phenomena

Recurrence

Chemicals & Drugs

Norfloxacin

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Cervera Carlos; Balderramo Domingo; Suárez Belén; Prieto Jhon; Fuster Francisco; Linares Laura; Fuster Josep; Moreno Asunción; Lozano Francisco; Navasa Miquel
Donor mannose-binding lectin gene polymorphisms influence the outcome of liver transplantation.
Cervera C; Lozano F; Linares L; Antón A; Balderramo D; Suárez B; Pascal M; Sanclemente G; Cofán F; Ricart M J; Navasa M; Roig E; Marcos M A; Pumarola T; Moreno A
Influence of mannose-binding lectin gene polymorphisms on the invasiveness of cytomegalovirus disease after solid organ transplantation.
Ramirez S; Perez-Del-Pulgar S; Carrion J A; Costa J; Gonzalez P; Massaguer A; Fondevila C; Garcia-Valdecasas J C; Navasa M; Forns X
Hepatitis C virus compartmentalization and infection recurrence after liver transplantation.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Miquel Navasa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Cervera Carlos; Balderramo Domingo; Suárez Belén; Prieto Jhon; Fuster Francisco; Linares Laura; Fuster Josep; Moreno Asunción; Lozano Francisco; Navasa Miquel
Donor mannose-binding lectin gene polymorphisms influence the outcome of liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2009;15(10):1217-24.
2009: Cervera C; Lozano F; Linares L; Antón A; Balderramo D; Suárez B; Pascal M; Sanclemente G; Cofán F; Ricart M J; Navasa M; Roig E; Marcos M A; Pumarola T; Moreno A
Influence of mannose-binding lectin gene polymorphisms on the invasiveness of cytomegalovirus disease after solid organ transplantation.
Transplantation proceedings 2009;41(6):2259-61.
2009: Ramirez S; Perez-Del-Pulgar S; Carrion J A; Costa J; Gonzalez P; Massaguer A; Fondevila C; Garcia-Valdecasas J C; Navasa M; Forns X
Hepatitis C virus compartmentalization and infection recurrence after liver transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009;9(7):1591-601.
2009: Carrión Jose A; Martínez-Bauer Eva; Crespo Gonzalo; Ramírez Santseharay; Pérez-del-Pulgar Sofia; García-Valdecasas Juan Carlos; Navasa Miquel; Forns Xavier
Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study.
Journal of hepatology 2009;50(4):719-28.
2009: Xiol Xavier; Gines Pere; Castells Lluis; Twose Jorge; Ribalta Alba; Fuentes-Arderiu Xavier; Rodriguez Santiago; Castellote Jose; Navasa Miquel; Deulofeu Roser
Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2009;15(3):300-5.
2009: Monegal Ana; Guañabens Núria; Suárez María Jesús; Suárez Francisco; Clemente Gerardo; García-González Miguel; De la Mata Manuel; Serrano Trinidad; Casafont Fernando; Tome Santiago; Barrios Cesar; Navasa Miquel
Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.
Transplant international : official journal of the European Society for Organ Transplantation 2009;22(2):198-206.
2008: Crespo Gonzalo; Cervera Carlos; Michelena Javier; Marco Francesc; Moreno Asunción; Navasa Miquel
Immune reconstitution syndrome after voriconazole treatment for cryptococcal meningitis in a liver transplant recipient.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008;14(11):1671-4.
2008: Navasa Miquel; Forns Xavier
How accurately and how early can we predict rapid fibrosis progression in hepatitis C virus-infected patients after liver transplantation?
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008;14(9):1237-9.
2008: Carrión Jose A; Navasa Miquel; Forns Xavier
MR elastography to assess liver fibrosis.
Radiology 2008;247(2):591; author reply 591-2.
2007: Herrero J I; Benlloch S; Bernardos A; Bilbao I; Castells L; Castroagudin J F; González L; Irastorza I; Navasa M; Otero A; Pons J A; Rimola A; Suárez F; Casanovas T; Otero E; Rodríguez M; Serrano T; Otero S; López I; Miras M; Prieto M;
Gastrointestinal complications in liver transplant recipients: MITOS study.
Transplantation proceedings 2007;39(7):2311-3.
2007: Cervera C; Filella X; Linares L; Pineda M; Esteva C; Antón A; Marcos M A; Cofán F; Navasa M; Pérez-Villa F; Pumarola T; Moreno A
TH1/TH2 cytokine release pattern during in vivo cytomegalovirus disease in solid organ transplantation.
Transplantation proceedings 2007;39(7):2233-5.
2007: Cervera C; Pineda M; Linares L; Marcos M A; Esteva C; Antón A; Cofán F; Ricart M J; Navasa M; Pérez-Villa F; Pumarola T; Moreno A
Impact of valganciclovir prophylaxis on the development of severe late-cytomegalovirus disease in high-risk solid organ transplant recipients.
Transplantation proceedings 2007;39(7):2228-30.
2007: Fernández Javier; Navasa Miquel; Planas Ramón; Montoliu Silvia; Monfort David; Soriano German; Vila Carmen; Pardo Alberto; Quintero Enrique; Vargas Victor; Such Jose; Ginès Pere; Arroyo Vicente
Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.
Gastroenterology 2007;133(3):818-24.
2007: Fica A; Cervera C; Pérez N; Marcos M A; Ramírez J; Linares L; Soto G; Navasa M; Cofan F; Ricart M J; Pérez-Villa F; Pumarola T; Moreno A
Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests.
Transplant infectious disease : an official journal of the Transplantation Society 2007;9(3):203-10.
2007: Londoño Maria-Carlota; Cárdenas Andrés; Guevara Mónica; Quintó Llorenç; de Las Heras Dara; Navasa Miguel; Rimola Antoni; Garcia-Valdecasas Juan-Carlos; Arroyo Vicente; Ginès Pere
MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.
Gut 2007;56(9):1283-90.
2007: Amador A; Charco R; Martí J; Navasa M; Rimola A; Calatayud D; Rodriguez-Laiz G; Ferrer J; Romero J; Ginesta C; Fondevila C; Fuster J; García-Valdecasas J C
Clinical trial on the cost-effectiveness of T-tube use in an established deceased donor liver transplantation program.
Clinical transplantation 2007;21(4):548-53.
2007: Fondevila C; Hessheimer A J; Ruiz A; Calatayud D; Ferrer J; Charco R; Fuster J; Navasa M; Rimola A; Taurá P; Ginés P; Manyalich M; García-Valdecasas J C
Liver transplant using donors after unexpected cardiac death: novel preservation protocol and acceptance criteria.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(7):1849-55.
2007: Carrión José A; Navasa Miquel; García-Retortillo Montserrat; García-Pagan Juan Carlos; Crespo Gonzalo; Bruguera Miquel; Bosch Jaime; Forns Xavier
Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.
Gastroenterology 2007;132(5):1746-56.
2007: Monegal Ana; Navasa Miquel; Peris Pilar; Alvarez Luisa; Pons Francesca; Rodés Joan; Guañabens Nuria
Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(4):492-7.
2007: Morales-Ruiz M; Fondevila C; Muñoz-Luque J; Tugues S; Rodríguez-Laiz G; Cejudo-Martín P; Romero J M; Navasa M; Fuster J; Arroyo V; Sessa W C; García-Valdecasas J C; Jiménez W
Gene transduction of an active mutant of akt exerts cytoprotection and reduces graft injury after liver transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(4):769-78.
2007: Sigal Samuel H; Stanca Carmen M; Fernandez Javier; Arroyo Vicente; Navasa Miguel
Restricted use of albumin for spontaneous bacterial peritonitis.
Gut 2007;56(4):597-9.
2007: Navasa Miquel; Forns Xavier
Antiviral therapy in HCV decompensated cirrhosis: to treat or not to treat?
Journal of hepatology 2007;46(2):185-8.
2006: Carrión Jose A; Navasa Miquel; Bosch Jaume; Bruguera Miquel; Gilabert Rosa; Forns Xavier
Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2006;12(12):1791-8.
2006: Fernández Javier; Escorsell Angels; Zabalza Michel; Felipe Vanessa; Navasa Miguel; Mas Antoni; Lacy Antonio M; Ginès Pere; Arroyo Vicente
Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival.
Hepatology (Baltimore, Md.) 2006;44(5):1288-95.
2006: Fernández Javier; Ruiz del Arbol Luis; Gómez Cristina; Durandez Rosa; Serradilla Regina; Guarner Carlos; Planas Ramón; Arroyo Vicente; Navasa Miguel
Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
Gastroenterology 2006;131(4):1049-56; quiz 1285.
2006: Martínez-Palli Graciela; Gómez Federico P; Barberà Joan A; Navasa Miquel; Roca Josep; Rodríguez-Roisin Robert; Burgos Felip; Gistau Conchi
Sustained low diffusing capacity in hepatopulmonary syndrome after liver transplantation.
World journal of gastroenterology : WJG 2006;12(36):5878-83.
2006: Cervera Carlos; Agustí Carlos; Angeles Marcos María; Pumarola Tomás; Cofán Federico; Navasa Miguel; Pérez-Villa Félix; Torres Antonio; Moreno Asunción
Microbiologic features and outcome of pneumonia in transplanted patients.
Diagnostic microbiology and infectious disease 2006;55(1):47-54.
2006: Londoño Maria-Carlota; Guevara Mónica; Rimola Antoni; Navasa Miquel; Taurà Pilar; Mas Antoni; García-Valdecasas Juan-Carlos; Arroyo Vicente; Ginès Pere
Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation.
Gastroenterology 2006;130(4):1135-43.
2006: Blasco Alejandro; Forns Xavier; Carrión José A; García-Pagán Juan Carlos; Gilabert Rosa; Rimola Antoni; Miquel Rosa; Bruguera Miquel; García-Valdecasas Juan-Carlos; Bosch Jaime; Navasa Miquel
Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation.
Hepatology (Baltimore, Md.) 2006;43(3):492-9.
2005: Terra Carlos; Guevara Mónica; Torre Aldo; Gilabert Rosa; Fernández Javier; Martín-Llahí Marta; Baccaro Maria E; Navasa Miquel; Bru Conxita; Arroyo Vicente; Rodés Juan; Ginès Pere
Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score.
Gastroenterology 2005;129(6):1944-53.
2005: Candel F J; Grima E; Matesanz M; Cervera C; Soto G; Almela M; Martínez J A; Navasa M; Cofán F; Ricart M J; Pérez-Villa F; Moreno A
Bacteremia and septic shock after solid-organ transplantation.
Transplantation proceedings 2005;37(9):4097-9.
2005: Trullas J C; Cervera C; Benito N; de la Bellacasa J Puig; Agustí C; Rovira M; Mas A; Navasa M; Cofan F; Ricart M J; Pérez-Villa F; Moreno A
Invasive pulmonary aspergillosis in solid organ and bone marrow transplant recipients.
Transplantation proceedings 2005;37(9):4091-3.
2005: Charco R; Rimola A; García-Valdecasas J C; Fuster J; Fondevila C; Navasa M; Julian M; Forta V; Brunet M
Steroids and living liver donation increase tacrolimus blood levels in living donor liver transplantation.
Transplantation proceedings 2005;37(9):3930-1.
2005: Amador A; Charco R; Martí J; Ferrer J; Mans E; Fondevila C; Fuster J; Grande L; Visa J; Rimola A; Navasa M; García-Valdecasas J Carlos
One thousand liver transplants: the hospital clinic experience.
Transplantation proceedings 2005;37(9):3916-8.
2005: Amador Auxiliadora; Charco Ramón; Martí Josep; Ferrer Joana; Mans Esther; Fondevila Constantino; Fuster Josep; Visa Josep; Rimola Antoni; Navasa Miguel; García-Valdecasas Juan Carlos; Grande Luis
[One thousand liver transplants. Hospital Clinic i Provincial de Barcelona (Spain)]
Cirugía española 2005;78(4):231-7.
2005: Fernández Javier; Monteagudo Joan; Bargallo Xavier; Jiménez Wladimiro; Bosch Jaume; Arroyo Vicente; Navasa Miguel
A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis.
Hepatology (Baltimore, Md.) 2005;42(3):627-34.
2005: Rimola Antoni; Llovet Josep M; Navasa Miquel; Bruix Jordi; Londoño María-Carlota; Fuster Josep; García-Valdecasas Juan-Carlos
Applicability of adult-to-adult living donor liver transplantation.
Journal of hepatology 2005;43(1):104-9.
2005: Massaguer Anna; Forns Xavier; Costa Josep; Feliu Anna; García-Retortillo Montserrat; Navasa Miquel; Rimola Antoni; García-Valdecasas Juan Carlos; Sánchez-Tapias José Maria
Performance of hepatitis C virus core antigen immunoassay in monitoring viral load after liver transplantation.
Transplantation 2005;79(10):1441-4.
2005: Forns Xavier; Martínez-Bauer Eva; Feliu Anna; García-Retortillo Montserrat; Martín Marta; Gay Eugeni; Navasa Miquel; Sánchez-Tapias Jose Maria; Bruguera Miquel; Rodés Juan
Nosocomial transmission of HCV in the liver unit of a tertiary care center.
Hepatology (Baltimore, Md.) 2005;41(1):115-22.
2004: Sala Margarita; Fuster Josep; Llovet Josep M; Navasa Miquel; Solé Manel; Varela María; Pons Fernando; Rimola Antoni; García-Valdecasas Juan Carlos; Brú Concepció; Bruix Jordi;
High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004;10(10):1294-300.
2004: Rimola Antoni; Londoño María-Carlota; Guevara Gonzalo; Bruguera Miquel; Navasa Miquel; Forns Xavier; García-Retortillo Montserrat; García-Valdecasas Juan-Carlos; Rodes Juan
Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation.
Transplantation 2004;78(5):686-91.
2004: Garcia-Retortillo Montserrat; Forns Xavier; Llovet Josep M; Navasa Miquel; Feliu Anna; Massaguer Anna; Bruguera Miquel; Fuster Josep; Garcia-Valdecasas Juan Carlos; Rimola Antoni
Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation.
Hepatology (Baltimore, Md.) 2004;40(3):699-707.
2004: Gómez Federico P; Martínez-Pallí Graciela; Barberà Joan A; Roca Josep; Navasa Miquel; Rodríguez-Roisin Robert
Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome.
Hepatology (Baltimore, Md.) 2004;40(3):660-6.
2004: Fernández Javier; Navasa Miguel; Garcia-Pagan Juan Carlos; G-Abraldes Juan; Jiménez Wladimiro; Bosch Jaume; Arroyo Vicente
Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.
Journal of hepatology 2004;41(3):384-90.
2004: Forns Xavier; Navasa Miquel; Rodés Juan
Treatment of HCV infection in patients with advanced cirrhosis.
Hepatology (Baltimore, Md.) 2004;40(2):498.
2004: Navasa Miguel; Rodés Juan
Bacterial infections in cirrhosis.
Liver international : official journal of the International Association for the Study of the Liver 2004;24(4):277-80.
2004: Ramírez María José; Titos Esther; Clària Joan; Navasa Miguel; Fernández Javier; Rodés Juan
Increased apoptosis dependent on caspase-3 activity in polymorphonuclear leukocytes from patients with cirrhosis and ascites.
Journal of hepatology 2004;41(1):44-8.
2004: Ramírez María José; Ibáñez Angel; Navasa Miguel; Casals Elena; Morales-Ruiz Manuel; Jiménez Wladimiro; Arroyo Vicente; Rodés Juan
High-density lipoproteins reduce the effect of endotoxin on cytokine production and systemic hemodynamics in cirrhotic rats with ascites.
Journal of hepatology 2004;40(3):424-30.
2004: Restuccia Tea; Ortega Rolando; Guevara Monica; Ginès Pere; Alessandria Carlo; Ozdogan Osman; Navasa Miquel; Rimola Antoni; Garcia-Valdecasas Juan Carlos; Arroyo Vicente; Rodés Juan
Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study.
Journal of hepatology 2004;40(1):140-6.
2003: García-Valdecasas J C; Fuster J; Charco R; Bombuy E; Fondevila C; Navasa M; Rodríguez-Laiz G; Ferrer J; Amador M A; Llovet J M; Forns X; Rimola A
[Adult living donor liver transplantation. Analysis of the first 30 cases]
Gastroenterología y hepatología 2003;26(9):525-30.
2003: Ruiz-del-Arbol Luis; Urman Jesús; Fernández Javier; González Mónica; Navasa Miguel; Monescillo Alberto; Albillos Agustín; Jiménez Wladimiro; Arroyo Vicente
Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.
Hepatology (Baltimore, Md.) 2003;38(5):1210-8.
2003: Varela M; Fernández J; Navasa M; Bruix J
Pseudotumoral hepatic tuberculosis.
Journal of hepatology 2003;39(4):654.
2003: Forns Xavier; García-Retortillo Montserrat; Serrano Trinidad; Feliu Anna; Suarez Francisco; de la Mata Manuel; García-Valdecasas Juan Carlos; Navasa Miquel; Rimola Antoni; Rodés Juan
Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation.
Journal of hepatology 2003;39(3):389-96.
2003: De las Heras Dara; Fernández Javier; Ginès Pere; Cárdenas Andres; Ortega Rolando; Navasa Miguel; Barberá Joan Albert; Calahorra Blas; Guevara Mónica; Bataller Ramón; Jiménez Wladimiro; Arroyo Vicente; Rodés Juan
Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis.
Hepatology (Baltimore, Md.) 2003;38(2):452-9.
2003: Vargas Víctor; Rimola Antoni; Casanovas Teresa; Castells Lluis; Navasa Miquel; Baliellas Carme; Bilbao Itxarone; Visa Josep; Jaurrieta Eduardo; Margarit Carlos
Applicability of liver transplantation in Catalonia at the end of the millennium. A prospective study of adult patient selection for liver transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 2003;16(4):270-5.
2002: Benito Natividad; Sued Omar; Moreno Asunción; Horcajada Juan P; González Julià; Navasa Miquel; Rimola Antoni
Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area.
Transplantation 2002;74(10):1381-6.
2002: Cejudo-Martín Pilar; Morales-Ruiz Manuel; Ros Josefa; Navasa Miguel; Fernández-Varo Guillermo; Fuster Josep; Rivera Francisca; Arroyo Vicente; Rodés Juan; Jiménez Wladimiro
Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients.
Hepatology (Baltimore, Md.) 2002;36(5):1172-9.
2002: Andreu Hernán; Rimola Antoni; Bruguera Miquel; Navasa Miquel; Cirera Isabel; Grande Luis; García-Valdecasas Juan-Carlos; Rodés Joan
Acute cellular rejection in liver transplant recipients under cyclosporine immunosuppression: predictive factors of response to antirejection therapy.
Transplantation 2002;73(12):1936-43.
2002: Bauer Tilman M; Follo Antonio; Navasa Miguel; Vila Jordi; Planas Ramon; Clemente Gerardo; Vargas Victor; Bory Felipe; Vaquer Pere; Rodés Juan
Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence.
Digestive diseases and sciences 2002;47(6):1356-61.
2002: Bauer Tilman Martin; Fernández Javier; Navasa Miquel; Vila Jordi; Rodés Juan
Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis.
Journal of hepatology 2002;36(4):501-6.
2002: Garcia-Retortillo Montserrat; Forns Xavier; Feliu Anna; Moitinho Eduardo; Costa Josep; Navasa Miquel; Rimola Antoni; Rodes Juan
Hepatitis C virus kinetics during and immediately after liver transplantation.
Hepatology (Baltimore, Md.) 2002;35(3):680-7.
2002: Heredia E N; Flores V; Grande L; Rimola A; Garcia-Valdecasas J C; Navasa M; Fuster J; Cirera I; Barros P; Sánchez S; Visa J
Liver function test and prevalence of associated diseases 5 years after liver transplantation.
Transplantation proceedings 2002;34(1):294.
2002: García-Valdecasas J C; Fuster J; Grande L; Fondevila C; Rimola A; Navasa M; Bombuy E; Ferrer J; Visa J
Adult living donor liver transplantation: initial results of a starting program.
Transplantation proceedings 2002;34(1):237-8.
2002: Fernández Javier; Navasa Miquel; Gómez Juliá; Colmenero Jordi; Vila Jordi; Arroyo Vicente; Rodés Juan
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Hepatology (Baltimore, Md.) 2002;35(1):140-8.
2001: Cejudo-Martín P; Ros J; Navasa M; Fernández J; Fernández-Varo G; Ruiz-del-Arbol L; Rivera F; Arroyo V; Rodés J; Jiménez W
Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis.
Hepatology (Baltimore, Md.) 2001;34(3):487-93.
2001: Rull R; Garcia Valdecasas J C; Grande L; Fuster J; Lacy A M; González F X; Rimola A; Navasa M; Iglesias C; Visa J
Intrahepatic biliary lesions after orthotopic liver transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 2001;14(3):129-34.
2001: García-Valdecasas J C; Fuster J; Grande L; Fondevila C; Rimola A; Navasa M; Cirera I; Bombuy E; Visa J
[Living donor liver transplantation in adults. Initial results]
Gastroenterología y hepatología 2001;24(6):275-80.
2001: Cirera I; Mas A; Salmerón J M; Jiménez D F; Sanjosé A; Navasa M; Rimola A; Roca M; Grande L; Garcia-Valdecasas J C; Rodés J
Reduced doses of hepatitis B immunoglobulin protect against hepatitis B virus infection recurrence after liver transplantation.
Transplantation proceedings 2001;33(4):2551-3.
2001: Cirera I; Bauer T M; Navasa M; Vila J; Grande L; Taurá P; Fuster J; García-Valdecasas J C; Lacy A; Suárez M J; Rimola A; Rodés J
Bacterial translocation of enteric organisms in patients with cirrhosis.
Journal of hepatology 2001;34(1):32-7.
2000: Llovet J M; Moitinho E; Sala M; Bataller R; Rodríguez-Iglesias P; Castells A; Fernández J; Planas R; Navasa M; Bruix J; Rodés J
Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis.
Journal of hepatology 2000;33(3):423-9.
2000: Uriz J; Ginès P; Cárdenas A; Sort P; Jiménez W; Salmerón J M; Bataller R; Mas A; Navasa M; Arroyo V; Rodés J
Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.
Journal of hepatology 2000;33(1):43-8.
2000: Cirera I; Navasa M; Rimola A; García-Pagán J C; Grande L; Garcia-Valdecasas J C; Fuster J; Bosch J; Rodes J
Ascites after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2000;6(2):157-62.
2000: Rimola A; García-Tsao G; Navasa M; Piddock L J; Planas R; Bernard B; Inadomi J M
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.
Journal of hepatology 2000;32(1):142-53.
1999: Fuster D; Navasa M; Pons F; Vidal-Sicart S; Mateos J J; Lomeña F; Rodes J; Herranz R
In-111 octreotide scan in a case of a neuroendocrine tumor of unknown origin.
Clinical nuclear medicine 1999;24(12):955-8.
1999: Grande L; Matus D; Manyalic M; Cabrer C; Rodriguez-Montalvo C; Rimola A; Navasa M; Garcia-Valdecasas J C; Visa J
Effect of donor age on graft outcome after liver transplantation.
Transplantation proceedings 1999;31(6):2482-3.
1999: Rodriguez-Montalvo C; Grande L; Rimola A; Mas A; Salmeron J M; Navasa M; García-Valdecasas J C; Matus D; Visa J
Use of perihepatic packing in the management of intraoperative hemorrhage in liver transplantation.
Transplantation proceedings 1999;31(6):2398-9.
1999: Grande L; Pérez-Castilla A; Matus D; Rodriguez-Montalvo C; Rimola A; Navasa M; García-Valdecasas J C; Visa J
Routine use of the T tube in the biliary reconstruction of liver transplantation: is it worthwhile?
Transplantation proceedings 1999;31(6):2396-7.
1999: Jiménez W; Ros J; Morales-Ruiz M; Navasa M; Solé M; Colmenero J; Sort P; Rivera F; Arroyo V; Rodés J
Nitric oxide production and inducible nitric oxide synthase expression in peritoneal macrophages of cirrhotic patients.
Hepatology (Baltimore, Md.) 1999;30(3):670-6.
1999: Sort P; Navasa M; Arroyo V; Aldeguer X; Planas R; Ruiz-del-Arbol L; Castells L; Vargas V; Soriano G; Guevara M; Ginès P; Rodés J
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
The New England journal of medicine 1999;341(6):403-9.
1999: Bustamante J; Rimola A; Ventura P J; Navasa M; Cirera I; Reggiardo V; Rodés J
Prognostic significance of hepatic encephalopathy in patients with cirrhosis.
Journal of hepatology 1999;30(5):890-5.
1999: Pérez-Ruiz M; Ros J; Morales-Ruiz M; Navasa M; Colmenero J; Ruiz-del-Arbol L; Cejudo P; Clária J; Rivera F; Arroyo V; Rodés J; Jiménez W
Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide.
Hepatology (Baltimore, Md.) 1999;29(4):1057-63.
1998: Llovet J M; Bruix J; Fuster J; Castells A; Garcia-Valdecasas J C; Grande L; Franca A; Brú C; Navasa M; Ayuso M C; Solé M; Real M I; Vilana R; Rimola A; Visa J; Rodés J
Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power.
Hepatology (Baltimore, Md.) 1998;27(6):1572-7.
1998: González E; Rimola A; Navasa M; Andreu H; Grande L; García-Valdecasas J C; Cirera I; Visa J; Rodés J
Liver transplantation in patients with non-biliary cirrhosis: prognostic value of preoperative factors.
Journal of hepatology 1998;28(2):320-8.
1997: Grande L; Rull A; Rimola A; Manyalic M; Cabrer C; Garcia-Valdecasas J C; Navasa M; Fuster J; Lacy A M; González F X; López-Boado M A; Visa J
Impact of donor gender on graft survival after liver transplantation.
Transplantation proceedings 1997;29(8):3373-4.
1997: Bessa X; Andreu H; Cirera I; Rimola A; Navasa M; Grande L; Visa J; Rodés J
[De novo tumors in adult patients with hepatic transplant]
Gastroenterología y hepatología 1997;20(9):442-5.
1997: Sort P; Ginés P; Navasa M; Arroyo V
[Current treatment of ascites and spontaneous bacterial peritonitis in Spain: analysis of a survey of gastroenterologists and hepatologists]
Gastroenterología y hepatología 1997;20(9):437-41.
1997: Navasa M; Rodés J
Management of ascites in the patient with portal hypertension with emphasis on spontaneous bacterial peritonitis.
Seminars in gastrointestinal disease 1997;8(4):200-9.
1997: Llovet J M; Rodríguez-Iglesias P; Moitinho E; Planas R; Bataller R; Navasa M; Menacho M; Pardo A; Castells A; Cabré E; Arroyo V; Gassull M A; Rodés J
Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes.
Journal of hepatology 1997;26(1):88-95.
1997: Pera M; García-Valdecasas J C; Grande L; Rimola A; Fuster J; Lacy A M; Cifuentes A; Cirera I; Navasa M; Visa J
Liver transplantation for alcoholic cirrhosis with anti-HCV antibodies.
Transplant international : official journal of the European Society for Organ Transplantation 1997;10(4):289-92.
1997: Sans M; Rimola A; Navasa M; Grande L; García-Valdecasas J C; Andreu H; Salmerón J M; Mas A; Rodés J
Liver transplantation in patients with Caroli's disease and recurrent cholangitis.
Transplant international : official journal of the European Society for Organ Transplantation 1997;10(3):241-4.
1996: Restrepo J C; Rimola A; Mas A; Navasa M; Salmerón J M; Cirera I; García-Valdecasas J C; Grande L; Visa J; Rodés J
[Prolonged administration of hepatitis B hyperimmune gamma globulin in patients with liver transplantation in liver diseases caused by hepatitis B virus]
Gastroenterología y hepatología 1996;19(10):491-6.
1996: Cirera I; Navasa M; Andreu H; García-Valdecasas J C; Grande L
[Indications and contraindications of liver transplantation]
Gastroenterología y hepatología 1996;19(8):394-400.
1996: Navasa M; Follo A; Llovet J M; Clemente G; Vargas V; Rimola A; Marco F; Guarner C; Forné M; Planas R; Bañares R; Castells L; Jimenez De Anta M T; Arroyo V; Rodés J
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.
Gastroenterology 1996;111(4):1011-7.
1996: Taura P; Garcia-Valdecasas J C; Beltran J; Izquierdo E; Navasa M; Sala-Blanch J; Mas A; Balust J; Grande L; Visa J
Moderate primary pulmonary hypertension in patients undergoing liver transplantation.
Anesthesia and analgesia 1996;83(4):675-80.
1996: Navasa M; Forns X; Sánchez V; Andreu H; Marcos V; Borràs J M; Rimola A; Grande L; García-Valdecasas J C; Granados A; Rodés J
Quality of life, major medical complications and hospital service utilization in patients with primary biliary cirrhosis after liver transplantation.
Journal of hepatology 1996;25(2):129-34.
1996: Navasa M; Bustamante J; Marroni C; González E; Andreu H; Esmatjes E; García-Valdecasas J C; Grande L; Cirera I; Rimola A; Rodés J
Diabetes mellitus after liver transplantation: prevalence and predictive factors.
Journal of hepatology 1996;25(1):64-71.
1996: Llach J; Bordas J M; Salmerón J M; Panés J; García-Pagán J C; Feu F; Navasa M; Mondelo F; Piqué J M; Mas A; Terés J; Rodés J
A prospective randomized trial of heater probe thermocoagulation versus injection therapy in peptic ulcer hemorrhage.
Gastrointestinal endoscopy 1996;43(2 Pt 1):117-20.
1995: García-Valdecasas J C; Prados M; Rimola A; Grande L; Segura J; Beltrán J; Fuster J; Lacy A M; González F X; Navasa M
Risk factors for severe bacterial infection after liver transplantation.
Transplantation proceedings 1995;27(4):2334-5.
1995: Rimola A; Navasa M; Arroyo V
Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis.
Diagnostic microbiology and infectious disease 1995;22(1-2):141-5.
1995: Saló J; Francitorra A; Follo A; Navasa M; Ginès A; Jiménez W; Ginès P; Arroyo V; Rivera F; Rodés J
Increased plasma endothelin in cirrhosis. Relationship with systemic endotoxemia and response to changes in effective blood volume.
Journal of hepatology 1995;22(4):389-98.
1995: Salgado M; Sans M; Forns X; Bruguera M; Castells A; Navasa M; Rodés J
[Hepatic angiosarcoma: a report of a case associated with treatment with arsenic salts and a review of the literature]
Gastroenterología y hepatología 1995;18(3):132-5.
1994: Follo A; Llovet J M; Navasa M; Planas R; Forns X; Francitorra A; Rimola A; Gassull M A; Arroyo V; Rodés J
Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis.
Hepatology (Baltimore, Md.) 1994;20(6):1495-501.
1994: Bosch J; Bruix J; Mas A; Navasa M; Rodés J
Rolling review: the treatment of major complications of cirrhosis.
Alimentary pharmacology & therapeutics 1994;8(6):639-57.
1994: Guañabens N; Parés A; Navasa M; Martínez de Osaba M J; Hernández M E; Muñoz J; Rodés J
Cyclosporin A increases the biochemical markers of bone remodeling in primary biliary cirrhosis.
Journal of hepatology 1994;21(1):24-8.
1994: Navasa M; Monegal A; Guañabens N; Peris P; Rimola A; Muñoz-Gómez J; Visa J; Rodés J
Bone fractures in liver transplant patients.
British journal of rheumatology 1994;33(1):52-5.
1994: Arroyo V; Navasa M; Rimola A
Spontaneous bacterial peritonitis in liver cirrhosis: treatment and prophylaxis.
Infection 1994;22 Suppl 3():S167-75.
1993: Castells A; Bruix J; Bru C; Fuster J; Vilana R; Navasa M; Ayuso C; Boix L; Visa J; Rodés J
Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection.
Hepatology (Baltimore, Md.) 1993;18(5):1121-6.
1993: Peris P; Navasa M; Guañabens N; Monegal A; Moya F; Brancós M A; Rimola A; Muñoz-Gómez J
Sacral stress fracture after liver transplantation.
British journal of rheumatology 1993;32(8):702-4.
1993: Castells A; Salmerón J M; Navasa M; Rimola A; Saló J; Andreu H; Mas A; Rodés J
Liver transplantation for acute liver failure: analysis of applicability.
Gastroenterology 1993;105(2):532-8.
1993: Ginès A; Escorsell A; Ginès P; Saló J; Jiménez W; Inglada L; Navasa M; Clària J; Rimola A; Arroyo V
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.
Gastroenterology 1993;105(1):229-36.
1993: Beltran J; Taura P; García-Valdecasas J C; Navasa M; Zavala E; Anglada T; Soley R; Alvarez L; Visa J
Neurological disorders and intraoperative factors in liver transplantation.
Transplantation proceedings 1993;25(2):1749-50.
1993: Arroyo V; Ginés P; Navasa M; Rimola A
Renal failure in cirrhosis and liver transplantation.
Transplantation proceedings 1993;25(2):1734-9.
1993: Navasa M; Feu F; García-Pagán J C; Jiménez W; Llach J; Rimola A; Bosch J; Rodés J
Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1993;17(3):355-60.
1993: Panés J; Caballería J; Guitart R; Parés A; Soler X; Rodamilans M; Navasa M; Parés X; Bosch J; Rodés J
Determinants of ethanol and acetaldehyde metabolism in chronic alcoholics.
Alcoholism, clinical and experimental research 1993;17(1):48-53.
1993: Carreras E; Grañena A; Navasa M; Bruguera M; Marco V; Sierra J; Tassies M D; García-Pagán J C; Martí J M; Bosch J
On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease.
Annals of hematology 1993;66(2):77-80.
1993: Toledo C; Salmerón J M; Rimola A; Navasa M; Arroyo V; Llach J; Ginès A; Ginès P; Rodés J
Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime.
Hepatology (Baltimore, Md.) 1993;17(2):251-7.
1993: Carreras E; Grañena A; Navasa M; Bruguera M; Marco V; Sierra J; Tassies M D; García-Pagán J C; Martí J M; Bosch J
Transjugular liver biopsy in BMT.
Bone marrow transplantation 1993;11(1):21-6.
1992: Llach J; Rimola A; Navasa M; Ginès P; Salmerón J M; Ginès A; Arroyo V; Rodés J
Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration.
Hepatology (Baltimore, Md.) 1992;16(3):724-7.
1992: Navasa M; Garcia-Pagán J C; Bosch J; Riera J R; Bañares R; Mas A; Bruguera M; Rodés J
Portal hypertension in acute liver failure.
Gut 1992;33(7):965-8.
1992: García-Pagán J C; Navasa M; Rivera F; Bosch J; Rodés J
Lymphocyte beta 2-adrenoceptors and plasma catecholamines in patients with cirrhosis.
Gastroenterology 1992;102(6):2015-23.
1992: García-Valdecasas J C; González F J; Grande L; Rimola A; Navasa M; Fuster J; Lacy A M; Cugat E; Visa J
The use of the University of Wisconsin (UW) and Euro-Collins (EC) solutions either alone or in a combined method.
Transplant international : official journal of the European Society for Organ Transplantation 1992;5(2):77-80.
1992: Lacy A M; Navasa M; Gilabert R; Brú C; García-Pagán J C; García-Valdecasas J C; Grande L; Feu F; Fuster J; Terés J
Long-term effects of distal splenorenal shunt on hepatic hemodynamics and liver function in patients with cirrhosis: importance of reversal of portal blood flow.
Hepatology (Baltimore, Md.) 1992;15(4):616-22.
1992: Salmerón J M; Titó L; Rimola A; Mas A; Navasa M A; Llach J; Ginès A; Ginès P; Arroyo V; Rodés J
Selective intestinal decontamination in the prevention of bacterial infection in patients with acute liver failure.
Journal of hepatology 1992;14(2-3):280-5.
1990: García-Pagán J C; Feu F; Navasa M; Bru C; Ruiz del Arbol L; Bosch J; Rodés J
Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.
Journal of hepatology 1990;11(2):189-95.
1990: Silva G; Navasa M; Bosch J; Chesta J; Pilar Pizcueta M; Casamitjana R; Rivera F; Rodés J
Hemodynamic effects of glucagon in portal hypertension.
Hepatology (Baltimore, Md.) 1990;11(4):668-73.
1990: Garcia-Pagán J C; Navasa M; Bosch J; Bru C; Pizcueta P; Rodés J
Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1990;11(2):230-8.
1989: Bosch J; Groszmann R J; García-Pagán J C; Terés J; García-Tsao G; Navasa M; Mas A; Rodés J
Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: a placebo-controlled clinical trial.
Hepatology (Baltimore, Md.) 1989;10(6):962-8.
1989: Mastai R; Bosch J; Bruix J; Navasa M; Kravetz D; Rodés J
Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1989;10(3):269-72.
1989: Bosch J; Navasa M; Garcia-Pagán J C; DeLacy A M; Rodés J
Portal hypertension.
The Medical clinics of North America 1989;73(4):931-53.
1989: Navasa M; Chesta J; Bosch J; Rodés J
Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
Gastroenterology 1989;96(4):1110-8.
1989: Rigau J; Bosch J; Bordas J M; Navasa M; Mastai R; Kravetz D; Bruix J; Feu F; Rodés J
Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage.
Gastroenterology 1989;96(3):873-80.
1989: Bosch J; Pagán J C; Bruix J; Ruiz del Arbol L; Pizcueta M P; Navasa M; Feu F; Bru C; Rodés J
Evaluation of the portal hypertensive patient.
Journal of gastroenterology and hepatology 1989;4 Suppl 1():39-47.
1988: Bosch J; Navasa M; Kravetz D; Pizcueta M P; García-Pagán J C; De Lacy A M; Rodés J
Diagnosis and evaluation of portal hypertension.
Zeitschrift für Gastroenterologie 1988;26 Suppl 2():8-14.
1988: Bosch J; Bordas J M; Mastai R; Kravetz D; Navasa M; Chesta J; Pizcueta M P; García-Pagán J C; Rodés J
Effects of vasopressin on the intravariceal pressure in patients with cirrhosis: comparison with the effects on portal pressure.
Hepatology (Baltimore, Md.) 1988;8(4):861-5.
1988: Navasa M; Bosch J; Reichen J; Bru C; Mastai R; Zysset T; Silva G; Chesta J; Rodés J
Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension.
Hepatology (Baltimore, Md.) 1988;8(4):850-4.
1988: Silva G; Gomis R; Bosch J; Casamitjana R; Mastai R; Navasa M; Rivera F; Rodés J
Hyperglucagonism and glucagon resistance in cirrhosis. Paradoxical effect of propranolol on plasma glucagon levels.
Journal of hepatology 1988;6(3):325-31.
1988: Ginès P; Jiménez W; Arroyo V; Navasa M; López C; Titó L; Serra A; Bosch J; Sanz G; Rivera F
Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction.
Hepatology (Baltimore, Md.) 1988;8(3):636-42.
1988: Bosch J; Kravetz D; Mastai R; Navasa M; Silva G; Chesta J; Rodes J
Effects of somatostatin in patients with portal hypertension.
Hormone research 1988;29(2-3):99-102.
1987: Navasa M; Parés A; Bruguera M; Caballería J; Bosch J; Rodés J
Portal hypertension in primary biliary cirrhosis. Relationship with histological features.
Journal of hepatology 1987;5(3):292-8.
1987: Mastai R; Bosch J; Navasa M; Kravetz D; Bruix J; Viola C; Rodés J
Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis.
Journal of hepatology 1987;4(1):71-9.
1986: Mastai R; Grande L; Bosch J; Bruix J; Rigau J; Kravetz D; Navasa M; Pera C; Rodés J
Effects of metoclopramide and domperidone on azygos venous blood flow in patients with cirrhosis and portal hypertension.
Hepatology (Baltimore, Md.) 1986;6(6):1244-7.
1986: Bosch J; Mastai R; Kravetz D; Navasa M; Rodés J
Hemodynamic evaluation of the patient with portal hypertension.
Seminars in liver disease 1986;6(4):309-17.
1986: Bosch J; Bordas J M; Rigau J; Viola C; Mastai R; Kravetz D; Navasa M; Rodés J
Noninvasive measurement of the pressure of esophageal varices using an endoscopic gauge: comparison with measurements by variceal puncture in patients undergoing endoscopic sclerotherapy.
Hepatology (Baltimore, Md.) 1986;6(4):667-72.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Miquel Navasa

Research Profile (preview)

Disorders

Procedures

Physiology

Anatomy

Concepts & Ideas

Phenomena

Chemicals & Drugs

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Miquel Navasa (preview)

All Publications